Breaking News
March 20, 2019 - SSB and Novasep collaborate to develop new membrane chromatography systems
March 20, 2019 - Leaky valve repair improves quality of life in heart failure patients
March 20, 2019 - Diattenuation Imaging offers structural information of difficult to access brain regions
March 20, 2019 - Early sports specialization linked to increased injury rates during athletic career
March 20, 2019 - Study brings clarity about milk intake for children with Duarte galactosemia
March 20, 2019 - Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
March 20, 2019 - Maternal smoking during pregnancy increases risk of ADHD among offspring up to three-fold
March 20, 2019 - Pioneering pediatric kidney transplant surgeon Oscar Salvatierra dies at 83 | News Center
March 20, 2019 - F.D.A. Approves First Drug for Postpartum Depression
March 20, 2019 - TB remains a major public health challenge in the European region
March 20, 2019 - Most pills contain common allergens, warn experts
March 20, 2019 - Researchers discover previously unknown mechanism by which cells can sense oxygen
March 20, 2019 - World’s leading source of data on diagnosis, treatments for aortic dissection
March 20, 2019 - Breast cancer relapse predictor may soon be a reality
March 20, 2019 - Researchers identify origin of chronic pain in humans
March 20, 2019 - Two-drug combinations containing calcium channel blocker significantly lowers BP
March 20, 2019 - King’s scientists to monitor air quality exposure of 250 children
March 20, 2019 - Preventative cardioverter defibrillator implantation is of little benefit to kidney dialysis patients
March 20, 2019 - Merck to collaborate with GenScript for plasmid and virus manufacturing in China
March 20, 2019 - FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 20, 2019 - Study examines long-term opioid use in patients with severe osteoarthritis
March 20, 2019 - Retired Stanford professor Edward Rubenstein, pioneer in intensive care medicine, dies at 94 | News Center
March 20, 2019 - Aaron Diamond AIDS Research Center to Join Columbia University
March 20, 2019 - Call for halt to human gene editing and designer babies experiments
March 20, 2019 - Study illuminates how hot spots of genetic variation evolved in the human genome
March 20, 2019 - Roundworm study suggests alternatives for treatment of schizophrenia
March 20, 2019 - Sphingotec reports new applications of bio-ADM at 39th ISICEM
March 20, 2019 - Preventing falls through free community-based screenings for older adults
March 20, 2019 - AAOS: Supplement Use Low in Patients With Osteoporosis, Hip Fracture
March 20, 2019 - Does intensive blood pressure control reduce dementia?
March 20, 2019 - Nut consumption could be key to better cognitive health in older people
March 20, 2019 - Drinking hot tea associated with increased risk of esophageal cancer
March 20, 2019 - Androgen receptor plays vital role in regulating multiple mitochondrial processes
March 20, 2019 - NIH announces funding boost for Detroit Cardiovascular Training Program
March 20, 2019 - Study reveals another surgical option for patients with irreparable rotator cuff tears
March 20, 2019 - New robot-guided video game may be effective and low-cost solution for caregivers
March 20, 2019 - Heart Attacks Fall By One-Third Among Older Americans
March 20, 2019 - Data sharing uncovers five new risk genes for Alzheimer’s disease
March 20, 2019 - Does It Make Sense To Delay Children’s Vaccines?
March 20, 2019 - Lack of health insurance may increase Aging immigrants’ risk for cardiovascular disease
March 20, 2019 - Piece of puzzle unlocked in what drives alcohol addiction
March 20, 2019 - Researchers investigate whether Zika reservoirs are found in the Americas
March 20, 2019 - Compounds found in coffee may inhibit growth of prostate cancer
March 20, 2019 - Lab Innovations returns to the NEC on 30 & 31 October 2019
March 20, 2019 - How genes affect tobacco and alcohol use
March 20, 2019 - Osteoarthritis and rheumatoid arthritis have similar impacts on patients
March 20, 2019 - Individuals with infection history have higher risk of developing Sjögren’s syndrome
March 20, 2019 - Nursing home residents benefit from individualized multi-component exercise program
March 20, 2019 - Plant cellulose bone implants are “viable” option to support new bone growth, study finds
March 20, 2019 - Older people living in retirement communities benefit from improved health
March 20, 2019 - UTSA professor helps train first responders to detect prescription opioid overdoses
March 20, 2019 - Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
March 20, 2019 - Smoking may limit body’s ability to fight dangerous form of skin cancer
March 20, 2019 - Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
March 20, 2019 - TGen and ABL sign agreement to distribute new TB test technology
March 20, 2019 - UCD researchers lead development of new urine test to detect prostate cancer
March 20, 2019 - Miniature brains that can move muscles, grown in the lab
March 20, 2019 - Servier and Oncodesign announce research and drug development partnership
March 20, 2019 - FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
March 20, 2019 - TB Medicine Pretomanid Enters Regulatory Review Process in the United States
March 20, 2019 - Breastfeeding can erase effects of prenatal violence for newborns
March 20, 2019 - Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
March 20, 2019 - Space worries – shingles affecting astronauts says NASA
March 20, 2019 - Study shows how AI can improve physicians’ diagnostic accuracy
March 20, 2019 - Dolomite Bio launches new scRNA-Seq Reagent Kit at AGBT 2019
March 20, 2019 - World’s oldest semen viable for artificial insemination
March 20, 2019 - FDA Approves Zulresso (brexanolone) for the Treatment of Post-Partum Depression
March 19, 2019 - How it manipulates us to tribalism
March 19, 2019 - How can doctors encourage patients to adopt healthier behaviors?
March 19, 2019 - Meet Hal: He's One Sick Robot
March 19, 2019 - Blood test and mathematical model can estimate preterm birth rate in low-resource countries
March 19, 2019 - TAVR procedure safe in patients with unusual valve anatomy
March 19, 2019 - Proteins in the eye may be potential source for cost-effective test to predict Alzheimer’s disease
March 19, 2019 - Opioid Prescriptions Dropped for New Users From 2012 to 2017
March 19, 2019 - New method may better predict the best treatment for burn wounds
March 19, 2019 - “Asian” isn’t specific enough for health data, research suggests
March 19, 2019 - ColumbiaDoctors Presents Honors for Outstanding Commitment to Patient Safety
March 19, 2019 - Innovative model identifies primate species with potential to transmit Zika in the Americas
March 19, 2019 - One-off surgery could offer hope to patients with high blood pressure
March 19, 2019 - Many pet owners interested in feeding their pets with plant-based diet
Researchers to investigate role of hormones in mosquito’s ability to use human blood for egg production

Researchers to investigate role of hormones in mosquito’s ability to use human blood for egg production

image_pdfDownload PDFimage_print

Entomologists at the University of California, Riverside have received a five-year grant of $2.44 million from the National Institute of Allergy and Infectious Diseases, or NIAID, to investigate the role hormones play in the female mosquito’s ability to use human blood for egg production.

Vector mosquitoes need vertebrate blood to develop each batch of their eggs. As a result, reproduction in female mosquitoes is closely linked to blood feeding. The NIAID funding — a competitive National Institutes of Health grant renewal — will allow the entomologists to introduce novel research tools for genetic manipulation, such as CRISPR, in their exploration of the genetic basis for the hormonal control of mosquito reproduction.

“A clear understanding of the molecular mechanisms regulating egg development in mosquitoes can play a critical role in our coming up with innovative and novel vector control methods,” said Alexander Raikhel, a distinguished professor of entomology who will lead the project along with Sourav Roy, an assistant professional researcher who received his doctorate at UCR and joined the Raikhel lab in 2011.

The research project, titled “Molecular Basis of Ecdysteroid Action in the Mosquito,” is expected to help Raikhel, Roy, and others in Raikhel’s lab identify targets that can block the reproduction of female mosquitoes, thereby resulting in significant declines in mosquito populations and the dangerous diseases they transmit.

Mosquitoes pose an enormous threat to humans on a global scale, killing about a million people each year. The two notable vectors of the most devastating mosquito-borne diseases to humans are Aedes aegypti — the principal vector for dengue, yellow fever, chikungunya virus, and, recently, Zika virus — and Anopheles gambiae, the vector for malaria.

The menace of mosquito-borne diseases has increased over the years due to fast-growing insecticide resistance, social complexities, climate change, and the lack of effective vaccines. Mosquitoes are largely present in countries with extreme poverty and, hence, cause severe morbidity and economic loss that impede further development.

“Alleviating these diseases is not only critical for protecting human life, but also for improving social progress in vulnerable communities,” said Raikhel, the UC Presidential Chair and the Mir Mulla Endowed Chair in the Department of Entomology. “Recent expansion of Aedes mosquitoes northward from Central America has become a looming threat generating a major public health concern.”

In 2016, a $1.1 billion spending effort to reduce the effects and spread of Zika was put forth after outbreaks in both Florida and Texas. The Centers for Disease Control and Prevention predicted migration of both disease vectors — the yellow-fever mosquito Aedes aegypti and the tiger mosquito Aedes albopictus — into many parts of the United States by 2017, and gave high priority to the development of vector control methods.

Roy, a broadly trained computational biologist and an expert on mosquito genomics who has worked on research related to gene regulation for more than 10 years, noted that a complete collapse of the mosquito population would be an ideal but largely unachievable outcome of the research.

“Rapidly proliferated organisms such as mosquitoes are fast-evolving and develop resistance to many control approaches,” he said. “A good example is resistance to pesticides, the development of which has devastated mosquito control and resulted in a mosquito population explosion. It is an unrealistic goal to see the complete end of vector mosquitoes. A significant decline in their population, however, is realistic . Combined with novel insecticides for mosquitoes and vaccines and anti-pathogen drugs, such approaches could significantly reduce mosquito populations and incidence of diseases they transmit.”

Raikhel explained that mosquitoes serve as vectors for harmful human diseases because disease pathogens use female mosquitoes for the obligatory stages of their life cycles. Each egg development cycle produces 100-150 eggs and transpires 3-4 times during a female’s lifespan.

“Therefore, specifically targeting mosquito reproduction can have a significant impact on reducing the current and future populations,” he said. “Since Aedes aegypti can transmit multiple viral diseases that circulate in the same geographical region, removing the vector entirely from the field can serve as an effective method to limit the spread of all viral diseases.”

In Aedes aegypti females, two major insect hormones — the juvenile hormone and the steroid hormone ecdysone — control reproduction and egg development. Female mosquitoes are unique in that they undergo a three-day maturation period after they emerge from pupae. Juvenile hormone, which occurs only in insects, regulates this stage. In particular, it does so by regulating genes that are essential for subsequent reproduction steps.

“As a result, female mosquitoes become ready for seeking hosts, blood feeding, and subsequent egg development,” Roy said. “They also develop into a disease transmitting vector. Thus, this feature of mosquito reproduction presents an exceptional opportunity for manipulating mosquito egg development with the goal of interrupting reproduction.”

After female mosquitoes take a blood meal, it is ecdysone that controls egg development. During this post-blood feeding stage, genes responsible for mosquito egg development undergo their sequential activation and shut down.

“We have identified several factors and hormones involved in these functions, such as insulin and ecdysone,” Raikhel said. “We discovered that ecdysone not only activates some genes but also shuts down others in the course of the reproductive cycle. In our previous studies, we worked out the mechanism by which ecdysone activates mosquito genes. But how ecdysone represses genes has not been observed in any insect, including mosquitoes.”

In the present grant cycle, the Raikhel lab intends to clarify this repressive action of ecdysone.

“It is possible that in understanding how important genes can be shut down naturally, we would get a clue to how this process can be manipulated to block egg development,” said Raikhel, a member of the National Academy of Sciences.

About author

Related Articles